Date of management change: October 15, 2020
South San Francisco, CA-based Neuron23 Appointed Nancy Stagliano as Chief Executive Officer and Chair
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
Nancy Stagliano is Chief Executive Officer and Chair at Neuron23. Previously, Nancy held various senior HR leadership roles in the industry.
News
Short ProfileName: Nancy Stagliano
Title: Chief Executive Officer and Chair
Company: Neuron23
Industry: Biotechnology
Current Contact InfoEmail: ***************@neuron23.com
Phone:.***.***.*95*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Jones Paul, Grigoriou Katerina, DeCourcy Jack, Craft Jeff, Laferte Scot, Carter Donna, Heban Christine, hall raymond, Miller Jonathan, Wilson Adrian, Quance Daniel
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
